Trials / Completed
CompletedNCT00395551
Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
A Single Center Study of the Safety and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects With CNV Secondary to Causes Other Than AMD.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Ophthalmic Consultants of Boston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether ranibizumab is effective in the treatment of choroidal neovascularization secondary to causes other then wet macular-degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ranibizumab | 0.5mg intravitreal injection |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2006-11-03
- Last updated
- 2010-01-08
Source: ClinicalTrials.gov record NCT00395551. Inclusion in this directory is not an endorsement.